Management of Tachycardia with Heart Rate of 127 bpm
The appropriate management for a patient with a heart rate of 127 bpm requires first determining if the patient is hemodynamically stable, identifying the type of tachycardia, and then implementing targeted therapy based on the underlying mechanism. 1
Initial Assessment
- Tachycardia is defined as a heart rate >100 beats per minute, with a heart rate of 127 bpm indicating supraventricular tachycardia (SVT) 1
- Assess for hemodynamic stability - look for signs of acute altered mental status, ischemic chest discomfort, acute heart failure, hypotension, or shock 1
- Evaluate for potential causes of tachycardia - determine if it's primary (arrhythmia as the cause) or secondary (physiologic response to another condition) 1
- Provide supplemental oxygen if hypoxemia is present, as hypoxemia is a common cause of tachycardia 1
Classification of Tachycardia
- Determine if the tachycardia is narrow-complex (QRS <0.12 second) or wide-complex (QRS ≥0.12 second) using 12-lead ECG 1
- Narrow-complex tachycardias include:
- Sinus tachycardia
- Atrial fibrillation
- Atrial flutter
- AV nodal reentry tachycardia (AVNRT)
- Accessory pathway-mediated tachycardia (AVRT)
- Focal atrial tachycardia (AT)
- Multifocal atrial tachycardia (MAT) 1
- Wide-complex tachycardias include:
- Ventricular tachycardia (VT)
- SVT with aberrancy
- Pre-excited tachycardias (Wolff-Parkinson-White syndrome)
- Ventricular paced rhythms 1
Management Algorithm
For Hemodynamically Unstable Patients:
- Immediate synchronized cardioversion is indicated for patients with tachycardia causing hemodynamic instability 1
For Hemodynamically Stable Patients:
Regular Narrow-Complex Tachycardia (likely SVT):
- First-line: IV adenosine (6 mg rapid IV push, followed by 12 mg if needed) 1
- Alternative: IV beta-blockers (e.g., esmolol), IV calcium channel blockers (diltiazem or verapamil) 1
- Esmolol is particularly useful for rapid control of ventricular rate in emergent circumstances where short-term control is desired 2
Irregular Narrow-Complex Tachycardia (likely atrial fibrillation, atrial flutter, or MAT):
Regular Wide-Complex Tachycardia (likely VT or SVT with aberrancy):
Irregular Wide-Complex Tachycardia:
- Consider pre-excited atrial fibrillation or polymorphic VT
- Avoid AV nodal blocking agents in suspected pre-excitation 1
Special Considerations
- For heart rates <150 bpm (as in this case with HR 127), symptoms of instability are less likely to be caused primarily by the tachycardia unless there is impaired ventricular function 1
- Persistent tachycardia can lead to tachycardia-induced cardiomyopathy, characterized by ventricular systolic dysfunction that is reversible with rate control 3, 4
- Women may experience more symptoms with SVT, including fatigue, near-syncope, and syncope 1
- Elderly patients with AVNRT are more prone to syncope or near-syncope despite generally slower tachycardia rates 1
Follow-up Management
- If SVT is diagnosed and successfully treated acutely, consider referral to an electrophysiologist for definitive management, especially if episodes are recurrent 1
- For paroxysmal SVT associated with syncope, transcatheter ablation may be the treatment of choice 1
- Monitor for recurrence of tachycardia as some patients may experience recurrent heart failure with uncontrolled tachyarrhythmia even after initial recovery 3
Pitfalls to Avoid
- Don't assume all wide-complex tachycardias are SVT with aberrancy - most are ventricular in origin 1
- Don't delay cardioversion in unstable patients while attempting pharmacological therapy 1
- Don't overlook underlying causes of tachycardia such as hyperthyroidism, anemia, fever, dehydration, or pain 1
- Don't administer verapamil for wide-complex tachycardias of unknown origin, as this may precipitate hemodynamic collapse in VT 1